Rubow S, Klopper J
Department of Nuclear Medicine, Tygerberg Hospital, South Africa.
Eur J Nucl Med. 1988;14(12):632-3. doi: 10.1007/BF00251790.
An investigation of 131I excretion into human milk after a therapeutic dose of 5142 MBq (139 mCi) 131I, in a patient who has had a thyroidectomy is presented. During the first 36 h, 17.4% of the administered dose was excreted into the milk. In addition to the known radiation risk, this may affect the quantity of 131I retained by the thyroid and metastases.
本文报告了对一名甲状腺切除术后患者给予5142 MBq(139 mCi)治疗剂量的131I后,131I在人乳中的排泄情况进行的调查。在最初的36小时内,给药剂量的17.4%排泄到了乳汁中。除了已知的辐射风险外,这可能会影响甲状腺和转移灶中131I的留存量。